Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
47.44
-4.15 (-8.04%)
At close: Jun 5, 2026, 4:00 PM EDT
47.08
-0.36 (-0.76%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Moderna Market Cap
Moderna has a market cap or net worth of $18.82 billion as of June 5, 2026. Its market cap has increased by 88.65% in one year.
Market Cap
18.82B
Enterprise Value
12.67B
1-Year Change
88.65%
Ranking
Category
Stock Price
$47.44
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $18.82B, an increase of 207.65%. That is a compound annual growth rate of 16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 18.82B | 63.36% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 31.68B |
| BeOne Medicines AG | 31.12B |
| Insmed | 22.74B |
| BioNTech SE | 22.66B |
| Roivant Sciences | 21.24B |
| Incyte | 20.23B |
| Genmab | 15.12B |
| Jazz Pharmaceuticals | 15.06B |